TREA

The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis

Follow

Information

  • Research Project
  • 10401197
  • ApplicationId
    10401197
  • Core Project Number
    UH3AR077748
  • Full Project Number
    4UH3AR077748-02
  • Serial Number
    077748
  • FOA Number
    RFA-HL-20-030
  • Sub Project Id
  • Project Start Date
    8/1/2020 - 5 years ago
  • Project End Date
    7/31/2025 - 4 months ago
  • Program Officer Name
    ZHENG, XINCHENG
  • Budget Start Date
    8/1/2021 - 4 years ago
  • Budget End Date
    7/31/2022 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    8/11/2021 - 4 years ago
Organizations
Information

The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis

IC Name
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
  • Activity
    UH3
  • Administering IC
    AR
  • Application Type
    4
  • Direct Cost Amount
    405000
  • Indirect Cost Amount
    228825
  • Total Cost
    633825
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    846
  • Ed Inst. Type
  • Funding ICs
    NIAMS:100000\OD:533825\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZHL1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    STEADMAN PHILIPPON RESEARCH INSTITUTE
  • Organization Department
  • Organization DUNS
    966298262
  • Organization City
    VAIL
  • Organization State
    CO
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    816575242
  • Organization District
    UNITED STATES